Advertisement

Neonatology pp 1143-1149 | Cite as

Bilirubin Metabolism, Unconjugated Hyperbilirubinemia, and Physiologic Neonatal Jaundice

  • Giovanna Bertini
  • Carlo Dani
Reference work entry

Abstract

Neonatal jaundice is a frequent problem in neonatology, but with the advent of phototherapy which has simplified its treatment, it no longer represents a major concern, but early hospital discharge of neonates has now resulted in a re-emergence of the risk of kernicterus. Neonatal jaundice is principally the result of an increased synthesis of bilirubin, of a transient deficiency of bilirubin conjugation, of a partial deficiency of hepatic bilirubin uptake and intracellular transport, and of an increased enterohepatic circulation of the pigment that limit bilirubin elimination. The fact that bilirubin production in the neonate is two or more times greater than in the adult per kilogram of body weight represents the mainstay of this condition. Prevention of kernicterus in full-term infants is based on the detection of neonates at risk for developing hyperbilirubinemia. The daily evaluation of transcutaneous bilirubin measurement gives additional information on the rise of serum bilirubin level and can help to distinguish physiological from nonphysiological hyperbilirubinemia. A significant hyperbilirubinemia is more frequent in infants born before term and in neonates who do not feed well and lose more than 10% of body weight. Each jaundiced newborn should receive a bilirubin measurement. Transcutaneous bilirubin (TcB) can be used as first step in order to reduce the number of invasive and painful blood sampling, but TSB measurement is always necessary when the level of bilirubin is high and for therapeutic decisions.

Abbreviations

C-N

Crigler-Najjar syndrome

CO

Carbon monoxide

COHbc

Carboxyhemoglobin corrected for inspired CO

TcB

Transcutaneous bilirubin

TSB

Total serum bilirubin

UGT

Uridin 5′-diphospho-glucuronosyltransferase

References

  1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297–316CrossRefGoogle Scholar
  2. Berardi A, Lugli L, Ferrari F et al (2006) Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate 90(4):243–246CrossRefGoogle Scholar
  3. Bertini G, Dani C, Tronchin M, Rubaltelli FF (2001) Is breastfeeding really favoring early neonatal jaundice? Pediatrics 107(3), E41CrossRefGoogle Scholar
  4. Hansen TW (1997) Acute management of extreme neonatal jaundice – the potential benefits of intensified phototherapy and interruption of enterohepatic circulation. Acta Paediatr 86:843–846CrossRefGoogle Scholar
  5. Jori G, Reddi E, Rubaltelli FF (1988) Structural and functional differences between fetal and adult serum albumin. Int J Pept Protein Res 31:17–21CrossRefGoogle Scholar
  6. Kaplan M, Renbaum P, Levi-Lahad A et al (1997) Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 94:12128–12132CrossRefGoogle Scholar
  7. Kaplan M, Hammerman C, Renbaum P et al (2000) Gilbert’s syndrome and hyperbilirubinemia in ABO-incompatible neonates. Lancet 356:652–653CrossRefGoogle Scholar
  8. Kaplan M, Hammerman C, Rubaltelli FF et al (2002) Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism. Hepatology 35:905–911CrossRefGoogle Scholar
  9. Maisels MJ, Newman TB (1995) Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 96:730–733PubMedGoogle Scholar
  10. Maruo Y, Nishizawa K, Sato H et al (2000) Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene. Pediatrics 106:e59CrossRefGoogle Scholar
  11. Romagnoli C, Barone G, Pratesi S, Raimondi F, Capasso L, Zecca E, Dani C (2014) Task force for hyperbilirubinaemia of the Italian society of neonatology. Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age. Ital J Pediatr 40:11CrossRefGoogle Scholar
  12. Rubaltelli FF (1993) Bilirubin metabolism in the newborn. Biol Neonate 63:133–138CrossRefGoogle Scholar
  13. Rubaltelli FF, Guerrini P, Reddi E, Jori G (1989) Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 84:728–731PubMedGoogle Scholar
  14. Rubaltelli FF, Novello A, Vilei MT, Muraca M (1994) Serum and bile bilirubin pigments in the differential diagnosis of Crigler-Najjar disease. Pediatrics 94:553–556PubMedGoogle Scholar
  15. Rubaltelli FF, Dario C, Zancan L (1995) Congenital nonobstructive, nonhemolytic jaundice: effect of tin-mesoporphyrin. Pediatrics 95:942–2PubMedGoogle Scholar
  16. Stevenson DK, Bartoletti AL, Ostrander CR, Johnson JD (1980) Pulmonary excretion of carbon monoxide in the human infants as an index of bilirubin production: IV: effects of breast-feeding and caloric intake in the first postnatal week. Pediatrics 65:1170–1172PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neonatal Intensive Care UnitCareggi University HospitalFlorenceItaly
  2. 2.Università degli Studi di FirenzeFlorenceItaly

Personalised recommendations